Financial Ratios Abu Qir Fertilizers & Chemical Industries Company (S.A.E)
Stocks
ABUK
EGS38191C010
Agricultural Chemicals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 70.03 EGP | -1.78% |
|
+3.03% | +37.31% |
| Fiscal Period: June | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 20.72 | 36.87 | 25.38 | 10.59 | 12.1 | |||||
Return on Total Capital | 27.42 | 46.81 | 31.08 | 13.57 | 15.67 | |||||
Return On Equity % | 46.38 | 69.2 | 62.06 | 44.86 | 28.66 | |||||
Return on Common Equity | 38.77 | 57.89 | 51.83 | 38.44 | 24.45 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 44.2 | 65.08 | 58.54 | 44.99 | 45.58 | |||||
SG&A Margin | 6.45 | 4.32 | 4.8 | 9.8 | 8.63 | |||||
EBITDA Margin % | 39.09 | 60.67 | 55.03 | 35.87 | 36.45 | |||||
EBITA Margin % | 37.8 | 60 | 54.44 | 35.22 | 35.72 | |||||
EBIT Margin % | 37.8 | 60 | 54.44 | 35.22 | 35.72 | |||||
Income From Continuing Operations Margin % | 39.78 | 55.44 | 67.91 | 72.75 | 40.81 | |||||
Net Income Margin % | 39.78 | 55.44 | 67.91 | 72.75 | 40.81 | |||||
Net Avail. For Common Margin % | 33.25 | 46.37 | 56.72 | 62.33 | 34.82 | |||||
Normalized Net Income Margin | 30.44 | 44.3 | 53.59 | 58.02 | 32.62 | |||||
Levered Free Cash Flow Margin | 22.39 | 45.35 | 36.9 | 13.33 | 26.01 | |||||
Unlevered Free Cash Flow Margin | 22.4 | 45.39 | 36.94 | 13.69 | 26.12 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.88 | 0.98 | 0.75 | 0.48 | 0.54 | |||||
Fixed Assets Turnover | 6.51 | 11.27 | 13.91 | 9.71 | 9.13 | |||||
Receivables Turnover (Average Receivables) | 75.21 | 93.33 | 95.69 | 74.39 | 124.55 | |||||
Inventory Turnover (Average Inventory) | 3.86 | 4.01 | 4.82 | 5.17 | 6.04 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 4.24 | 4.08 | 4.78 | 5.98 | 4.08 | |||||
Quick Ratio | 3.53 | 3.64 | 4.3 | 5.52 | 3.63 | |||||
Operating Cash Flow to Current Liabilities | 1.2 | 2.27 | 1.55 | 0.21 | 0.55 | |||||
Days Sales Outstanding (Average Receivables) | 4.85 | 3.91 | 3.81 | 4.92 | 2.93 | |||||
Days Outstanding Inventory (Average Inventory) | 94.66 | 91.08 | 75.68 | 70.86 | 60.43 | |||||
Average Days Payable Outstanding | 34.72 | 30.35 | 21.51 | 2.35 | 8.46 | |||||
Cash Conversion Cycle (Average Days) | 64.79 | 64.64 | 57.98 | 73.43 | 54.9 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 0 | 0 | 0.08 | 0.05 | 0.02 | |||||
Total Debt / Total Capital | 0 | 0 | 0.08 | 0.05 | 0.02 | |||||
LT Debt/Equity | - | - | - | - | - | |||||
Long-Term Debt / Total Capital | - | - | - | - | - | |||||
Total Liabilities / Total Assets | 22.93 | 20.41 | 17.08 | 21.72 | 23.88 | |||||
EBIT / Interest Expense | 2.27K | 800.42 | 1.01K | 60.39 | 197.67 | |||||
EBITDA / Interest Expense | 2.35K | 809.32 | 1.02K | 61.5 | 201.74 | |||||
(EBITDA - Capex) / Interest Expense | 2.25K | 792.13 | 1.01K | 57.63 | 192.28 | |||||
Total Debt / EBITDA | 0 | 0 | 0 | 0 | 0 | |||||
Net Debt / EBITDA | -2.09 | -1.43 | -2.01 | -3.88 | -2.78 | |||||
Total Debt / (EBITDA - Capex) | 0 | 0 | 0 | 0 | 0 | |||||
Net Debt / (EBITDA - Capex) | -2.18 | -1.46 | -2.04 | -4.14 | -2.92 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 12.15 | 84.75 | 32.01 | -14.45 | 23.68 | |||||
Gross Profit, 1 Yr. Growth % | 35.45 | 172.03 | 18.74 | -33.93 | 25.31 | |||||
EBITDA, 1 Yr. Growth % | 42.92 | 186.72 | 19.86 | -41.21 | 25.68 | |||||
EBITA, 1 Yr. Growth % | 43.94 | 193.27 | 19.9 | -41.62 | 25.42 | |||||
EBIT, 1 Yr. Growth % | 43.94 | 193.27 | 19.9 | -41.62 | 25.42 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 30.47 | 157.51 | 61.7 | -3.87 | -30.6 | |||||
Net Income, 1 Yr. Growth % | 30.47 | 157.51 | 61.7 | -3.87 | -30.6 | |||||
Normalized Net Income, 1 Yr. Growth % | 30.02 | 168.82 | 59.84 | -3.63 | -30.47 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 30.38 | 157.7 | 61.31 | -3.64 | -30.82 | |||||
Accounts Receivable, 1 Yr. Growth % | 110.23 | 19.72 | 36.28 | -5.68 | -47.81 | |||||
Inventory, 1 Yr. Growth % | 0.5 | 21.96 | 37.01 | 10.59 | 27.99 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 3.66 | 9.56 | 4.5 | 44.3 | 22.65 | |||||
Total Assets, 1 Yr. Growth % | 16.5 | 106.24 | 58.34 | 21.91 | -0.26 | |||||
Tangible Book Value, 1 Yr. Growth % | 22.95 | 112.98 | 64.97 | 22.74 | -2.93 | |||||
Common Equity, 1 Yr. Growth % | 22.95 | 112.98 | 64.97 | 22.8 | -3.02 | |||||
Cash From Operations, 1 Yr. Growth % | 55.9 | 259.07 | -4.56 | -86.4 | 250.82 | |||||
Capital Expenditures, 1 Yr. Growth % | -36.06 | 43.57 | -28.15 | 176.77 | -6.38 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 101.8 | 274.12 | 7.51 | -71.63 | 141.41 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 101.89 | 274.33 | 7.5 | -71 | 136.01 | |||||
Dividend Per Share, 1 Yr. Growth % | 8.33 | 130.77 | 66.67 | 50 | -20 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 1.47 | 43.94 | 56.17 | 6.51 | 2.86 | |||||
Gross Profit, 2 Yr. CAGR % | 6.56 | 91.95 | 79.73 | -11.44 | -9.01 | |||||
EBITDA, 2 Yr. CAGR % | 8.51 | 102.43 | 85.29 | -18.05 | -14.04 | |||||
EBITA, 2 Yr. CAGR % | 8.58 | 105.46 | 87.43 | -18.35 | -14.43 | |||||
EBIT, 2 Yr. CAGR % | 8.58 | 105.46 | 87.43 | -18.35 | -14.43 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 5.53 | 83.3 | 104.06 | 22.01 | -18.33 | |||||
Net Income, 2 Yr. CAGR % | 5.53 | 83.3 | 104.06 | 22.01 | -18.33 | |||||
Normalized Net Income, 2 Yr. CAGR % | 2.98 | 86.96 | 107.2 | 21.95 | -18.15 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 5.43 | 83.3 | 103.97 | 23.44 | -18.4 | |||||
Accounts Receivable, 2 Yr. CAGR % | 43.28 | 58.65 | 27.73 | 12.61 | -29.84 | |||||
Inventory, 2 Yr. CAGR % | 2.67 | 10.71 | 29.27 | 15.11 | 11.22 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 9.99 | 6.57 | 7 | 21.98 | 33.04 | |||||
Total Assets, 2 Yr. CAGR % | 9.45 | 55 | 80.71 | 37.52 | 10.3 | |||||
Tangible Book Value, 2 Yr. CAGR % | 15.58 | 61.82 | 87.44 | 36.3 | 9.18 | |||||
Common Equity, 2 Yr. CAGR % | 15.58 | 61.82 | 87.44 | 36.39 | 9.15 | |||||
Cash From Operations, 2 Yr. CAGR % | -3.96 | 136.6 | 85.12 | -67.02 | -30.93 | |||||
Capital Expenditures, 2 Yr. CAGR % | 6.12 | -4.19 | 1.57 | 41.02 | 60.97 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 17.02 | 174.76 | 100.48 | -42.24 | -17.24 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 17.04 | 174.9 | 100.52 | -41.48 | -17.27 | |||||
Dividend Per Share, 2 Yr. CAGR % | 0 | 58.11 | 96.12 | 58.11 | 9.54 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 5.38 | 23.91 | 39.85 | 27.98 | 11.95 | |||||
Gross Profit, 3 Yr. CAGR % | 13.47 | 45.64 | 63.56 | 28.74 | -0.58 | |||||
EBITDA, 3 Yr. CAGR % | 14.67 | 50.01 | 69.93 | 24.37 | -5.5 | |||||
EBITA, 3 Yr. CAGR % | 15.21 | 51.22 | 71.64 | 25 | -5.79 | |||||
EBIT, 3 Yr. CAGR % | 15.21 | 51.22 | 71.64 | 25 | -5.79 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 13.26 | 42.08 | 75.79 | 56.51 | 1.09 | |||||
Net Income, 3 Yr. CAGR % | 13.26 | 42.08 | 75.79 | 56.51 | 1.09 | |||||
Normalized Net Income, 3 Yr. CAGR % | 12.69 | 41.8 | 77.39 | 58.67 | 1.12 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 13.17 | 42.02 | 75.71 | 57.8 | 1.73 | |||||
Accounts Receivable, 3 Yr. CAGR % | 0.26 | 34.95 | 50.81 | 14.93 | -12.86 | |||||
Inventory, 3 Yr. CAGR % | 6.04 | 8.73 | 18.86 | 17.35 | 14.02 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 8.51 | 9.84 | 5.88 | 17.69 | 22.2 | |||||
Total Assets, 3 Yr. CAGR % | 11.29 | 35.18 | 56.11 | 57.41 | 23.58 | |||||
Tangible Book Value, 3 Yr. CAGR % | 19.64 | 41.7 | 62.87 | 58.16 | 21.74 | |||||
Common Equity, 3 Yr. CAGR % | 19.64 | 41.7 | 62.87 | 58.23 | 21.75 | |||||
Cash From Operations, 3 Yr. CAGR % | 2.37 | 49.06 | 74.82 | -26.9 | -27.46 | |||||
Capital Expenditures, 3 Yr. CAGR % | 9.97 | 17.37 | -12.95 | 41.86 | 23.02 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 5.26 | 72.38 | 100.91 | 7.64 | -6.96 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 5.27 | 72.44 | 100.97 | 8.6 | -6.85 | |||||
Dividend Per Share, 3 Yr. CAGR % | 5.73 | 32.15 | 60.91 | 79.35 | 25.99 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 17.57 | 22.08 | 23.34 | 16.63 | 23.79 | |||||
Gross Profit, 5 Yr. CAGR % | 24.6 | 38.84 | 36.39 | 19.36 | 29.35 | |||||
EBITDA, 5 Yr. CAGR % | 28.05 | 41.29 | 38.93 | 17.76 | 28.14 | |||||
EBITA, 5 Yr. CAGR % | 29.96 | 42.61 | 39.97 | 18.16 | 28.67 | |||||
EBIT, 5 Yr. CAGR % | 29.96 | 42.61 | 39.97 | 18.16 | 28.67 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 28.08 | 32.25 | 43.33 | 33.68 | 28.26 | |||||
Net Income, 5 Yr. CAGR % | 28.08 | 32.25 | 43.33 | 33.68 | 28.26 | |||||
Normalized Net Income, 5 Yr. CAGR % | 29.06 | 32.55 | 43.78 | 33.48 | 29.28 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 28.25 | 32.44 | 43.24 | 34.29 | 28.77 | |||||
Accounts Receivable, 5 Yr. CAGR % | 11.21 | 8.86 | 10.46 | 25.52 | 10.74 | |||||
Inventory, 5 Yr. CAGR % | 12.68 | 10.1 | 14.78 | 11.24 | 12.68 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 13.16 | 10.22 | 7.9 | 14.55 | 15.69 | |||||
Total Assets, 5 Yr. CAGR % | 17.53 | 27.09 | 35.1 | 36.11 | 35.3 | |||||
Tangible Book Value, 5 Yr. CAGR % | 22.55 | 33.71 | 43.18 | 39.51 | 36.42 | |||||
Common Equity, 5 Yr. CAGR % | 22.55 | 33.71 | 43.18 | 39.55 | 36.43 | |||||
Cash From Operations, 5 Yr. CAGR % | 21.54 | 42.45 | 29.74 | -18.47 | 16.4 | |||||
Capital Expenditures, 5 Yr. CAGR % | 17.99 | 8.87 | 6.53 | 26.31 | 11.31 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 19.53 | 40.45 | 36.2 | 11.3 | 43.46 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 19.54 | 40.48 | 36.22 | 11.9 | 43.58 | |||||
Dividend Per Share, 5 Yr. CAGR % | 5.49 | 23.36 | 35.37 | 41.98 | 37.97 |
Select your edition
All financial news and data tailored to specific country editions
















